Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
PETROCHINA
00857
5
KUNLUN ENERGY
00135
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 28.81%12.44B | 15.84%45.46B | 18.61%32.86B | 20.64%20.8B | 20.96%9.65B | -2.73%39.24B | -6.23%27.7B | -8.64%17.24B | -10.95%7.98B | 2.51%40.34B |
| Operating income | 28.81%12.44B | 15.84%45.46B | 18.61%32.86B | 20.64%20.8B | 20.96%9.65B | -2.73%39.24B | -6.23%27.7B | -8.64%17.24B | -10.95%7.98B | 2.51%40.34B |
| Cost of sales | -10.56%-6.24B | -3.67%-24.08B | -6.83%-17.74B | -10.88%-11.69B | -13.37%-5.64B | 3.10%-23.23B | 4.96%-16.6B | 6.85%-10.54B | 8.49%-4.98B | 3.54%-23.97B |
| Operating expenses | -10.56%-6.24B | -3.67%-24.08B | -6.83%-17.74B | -10.88%-11.69B | -13.37%-5.64B | 3.10%-23.23B | 4.96%-16.6B | 6.85%-10.54B | 8.49%-4.98B | 3.54%-23.97B |
| Gross profit | 54.46%6.2B | 33.48%21.38B | 36.23%15.12B | 35.99%9.11B | 33.51%4.01B | -2.18%16.02B | -8.06%11.1B | -11.31%6.7B | -14.75%3.01B | 12.86%16.37B |
| Selling expenses | 6.18%-182.06M | -8.25%-806.87M | -4.17%-569.38M | -10.31%-394.37M | -8.35%-194.05M | -6.33%-745.39M | -4.87%-546.58M | -1.15%-357.52M | -1.84%-179.09M | 4.18%-701.03M |
| Administrative expenses | -25.74%-751.69M | 6.80%-2.8B | -0.24%-1.97B | 2.33%-1.25B | 2.08%-597.79M | -0.49%-3.01B | 4.57%-1.96B | 3.69%-1.28B | 8.80%-610.5M | -1.74%-2.99B |
| Research and development expenses | -18.96%-266.96M | 9.61%-1.12B | 13.46%-825.65M | 19.15%-514.43M | 26.76%-224.41M | 14.03%-1.24B | 7.00%-954.04M | 4.61%-636.31M | 14.25%-306.4M | 10.74%-1.44B |
| Impairment and provision | 59.03%-91.19M | 31.92%-1.03B | -374.52%-733.8M | -490.34%-484.83M | -1,029.65%-222.56M | -321.55%-1.51B | 11.97%-154.64M | 43.20%-82.13M | -213.23%-19.7M | -43.99%-357.9M |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | -122.61%-110.43M | ---- | ---- | ---- | 62.22%-49.61M |
| -Other impairment is provision | 59.03%-91.19M | 26.54%-1.03B | -374.52%-733.8M | -490.34%-484.83M | -1,029.65%-222.56M | -353.57%-1.4B | 11.97%-154.64M | 43.20%-82.13M | -213.23%-19.7M | -162.87%-308.29M |
| Special items of operating profit | -56.78%598.41M | 319.59%8.18B | 875.83%3.56B | 329.31%3.09B | 218.40%1.38B | -15.66%1.95B | -78.54%364.5M | -52.07%719.4M | 10.44%434.87M | 24.61%2.31B |
| Operating profit | 32.37%5.51B | 107.64%23.8B | 85.88%14.58B | 88.66%9.56B | 78.88%4.16B | -13.09%11.46B | -21.48%7.84B | -22.82%5.07B | -14.23%2.32B | 21.86%13.19B |
| Financing cost | 54.17%-36.75M | -14.12%-306.49M | -37.64%-257.64M | -30.92%-168.81M | -30.04%-80.2M | -38.74%-268.57M | -20.82%-187.18M | -27.58%-128.94M | 3.90%-61.67M | -21.11%-193.58M |
| Share of profits of associates | 117.41%139M | 79.43%452.41M | 116.84%440.05M | 107.40%240.2M | 88.38%63.94M | 818.83%252.14M | 447.57%202.94M | 251.45%115.82M | 174.08%33.94M | 33.23%-35.08M |
| Share of profit from joint venture company | -152.24%-35K | 102.43%172K | 115.93%635K | 101.61%67K | -67.16%67K | 78.23%-7.07M | -158.57%-3.99M | -154.18%-4.17M | -97.55%204K | -618.83%-32.48M |
| Earning before tax | 35.35%5.61B | 109.34%23.95B | 87.93%14.76B | 90.73%9.63B | 80.32%4.14B | -11.51%11.44B | -19.71%7.85B | -21.04%5.05B | -11.94%2.3B | 21.77%12.93B |
| Tax | -65.97%-936.77M | -131.89%-4.57B | -125.98%-2.83B | -62.23%-1.25B | -66.72%-564.43M | 7.49%-1.97B | 23.30%-1.25B | 25.97%-768.71M | 19.98%-338.54M | -24.24%-2.13B |
| After-tax profit from continuing operations | 30.52%4.67B | 104.65%19.38B | 80.71%11.93B | 95.84%8.38B | 82.67%3.58B | -12.31%9.47B | -18.99%6.6B | -20.09%4.28B | -10.38%1.96B | 21.29%10.8B |
| Earning after tax | 30.52%4.67B | 104.65%19.38B | 80.71%11.93B | 95.84%8.38B | 82.67%3.58B | -12.31%9.47B | -18.99%6.6B | -20.09%4.28B | -10.38%1.96B | 21.29%10.8B |
| Minority shareholders should account for profits from continuing business | -53.76%19M | 59.70%175.73M | 85.87%127.65M | 135.06%96.43M | 146.83%41.08M | 2.15%110.03M | --68.68M | --41.02M | --16.64M | --107.72M |
| Minority shareholders should account for non-continuing business profits | ---- | 14.79%7.25M | ---- | ---- | --925K | --6.31M | ---- | ---- | ---- | ---- |
| Minority profit | -54.77%19M | 57.27%182.98M | 85.87%127.65M | 135.06%96.43M | 152.39%42M | 8.01%116.35M | -4.93%68.68M | -6.29%41.02M | -5.85%16.64M | 21.17%107.72M |
| Shareholders should account for profits from continuing business | 30.97%4.63B | 58.41%17.85B | 65.12%11.94B | 78.85%8.42B | 64.57%3.54B | 0.28%11.27B | --7.23B | --4.71B | --2.15B | --11.23B |
| Shareholders should account for profits from non-continuing business | 1,135.66%17.92M | 170.45%1.35B | 80.80%-133.53M | 71.85%-131.54M | 99.17%-1.73M | -251.47%-1.91B | ---695.6M | ---467.34M | ---207.59M | ---544.5M |
| Profit attributable to shareholders | 31.54%4.65B | 105.24%19.19B | 80.65%11.8B | 95.46%8.29B | 82.07%3.54B | -12.51%9.35B | -19.11%6.53B | -20.20%4.24B | -10.42%1.94B | 21.29%10.69B |
| Basic earnings per share | 28.23%1.59 | 107.41%6.72 | 84.89%4.16 | 100.00%2.92 | 85.07%1.24 | -10.99%3.24 | -18.18%2.25 | -19.34%1.46 | -9.46%0.67 | 20.93%3.64 |
| Diluted earnings per share | 27.42%1.58 | 105.90%6.63 | 83.93%4.12 | 99.31%2.89 | 87.88%1.24 | -10.80%3.22 | -17.95%2.24 | -18.99%1.45 | -8.33%0.66 | 28.01%3.61 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.